Skip to main content

Indian Journal of Hematology and Blood Transfusion

Ausgabe 2/2023

Inhalt (26 Artikel)

Original Article

Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation

Yaşa Gül Mutlu, Berrin Balik Aydin, Cem Erdogan, Deniz Kizilaslan, Hüseyin Saffet Beköz, Aliihsan Gemici, Leylagül Kaynar, Ömür Gökmen Sevindik

Original Article

Human Hematopoietic Stem Cells Co-cultured in 3D with Stromal Support to Optimize Lentiviral Vector-mediated Gene Transduction

Amir Asri Kojabad, Hadi Esmaeili Gouvarchin Ghaleh, Alireza Shahriary, Mahdieh Farzanehpour

Original Article

Hematopoietic stem cell Transplantation in Children with very Early Onset Inflammatory Bowel Disease Secondary to Monogenic Disorders of immune-dysregulation

SATISHKUMAR MEENA, HARIKA VARLA, VENKATESWARAN VELLAICHAMY SWAMINATHAN, RUMESH CHANDAR, INDIRA JAYAKUMAR, BALASUBRAMANIAM RAMAKRISHNAN, RAMYA UPPULURI, REVATHI RAJ

Original Article

Charlson Comorbidity Index (CCI) in Diffuse Large B-cell Lymphoma: A New Approach in a Multicenter Study

Rafet Eren, Istemi Serin, Suheyla Atak, Betul Zehra Pirdal, Nihan Nizam, Aliihsan Gemici, Demet Aydın, Naciye Demirel, Esma Evrim Dogan, Osman Yokus

Original Article

Exposure-Response Relationship of Posaconazole Suspension in Theprophylaxis of Invasive Fungal Infections in Patients with Acute Myeloid Leukemia

Manju Sengar, Hasmukh Jain, Sanyo D’souza, Sadhana Kannan, Smruti Mokal, Murari Gurjar, Madhavi Ambotkar, Neha Sharma, Mounika Boppanna, Vikram Gota

Original Article

Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma

Ayfer Geduk¹, Berrin Oztas, Baldan Huri Eryılmaz, Esra Terzi Demirsoy, Meral U. Menguc, Serkan Unal, Sinan Mersin, Merve Gokcen Polat, Kemal Aygun, Emel Merve Yenihayat, Hayrunnisa Albayrak, Hasim Atakan Erol, Sibel Balcı, Ozgur Mehtap¹, Pinar Tarkun¹, Abdullah Hacihanefioglu¹

Open Access Original Article

Genetic Variations of ferroportin-1(FPN1-8CG), TMPRSS6 (rs855791) and Hemojuvelin (I222N and G320V) Among a Cohort of Egyptian β-Thalassemia Major Patients

Nesrine El-Gharbawi, Iman Shaheen, Mona Hamdy, Somaya Elgawhary, Mohamed Samir, Baher Matta Hanna, Eman Yousief Ali, Eman Ahmed Youssef

ORIGINAL ARTICLE

A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients

Urmimala Bhattacharjee, Alka Khadwal, Nusrat Shafiq, Deepesh Lad, Prashant Sharma, Reena Das, Prateek Shukla, Arihant Jain, Gaurav Prakash, Pankaj Malhotra

Original Article

Genetic Spectrum in F13A1 Detected by Next-Generation Sequencing Among North Indian Patients with FXIII Deficiency

Ritika Sharma, Manu Jamwal, Namrata Singh, Prashant Sharma, Deepak Bansal, Amita Trehan, Pankaj Malhotra, Arihant Jain, Jasmina Ahluwalia, Reena Das, Narender Kumar

Original Article

Macrothrombocytopenia: Role of Automated Platelet Data in Diagnosis

Aanchal Bhola, Rashi Garg, Anuj Sharma, Neelam Gupta, Naveen Kakkar

Original Article

Comparison of Two Different Serological Viral Marker Testing Assays for Screening of Apheresis Donors: Which Assay Provides Optimum Safety for Transfusion?

Aseem K. Tiwari, Divya Setya, Ravi Dara, Dinesh Arora, Swati Pabbi Mehta, Geet Aggarwal, Gunjan Bhardwaj

Original Article

Economic Evaluation of Nucleic Acid Testing for Screening of Blood Donations for Thalassemia Patients (ECONAT) in Western India

Puneeth Babu Anne, Anubhav Gupta, Sanjeev Misra, Suresh Kumar Sharma, Mahendra Kumar Garg, Archana Bajpayee, Sunita Bundas, Manju Bohra, Vasanth Asirvatham

Short Communication

Higher mTOR Expression: A Marker of Poor Outcome in Patients with de Novo AML

Nahla Osman, Reham ELzayat, Iman ELtounsi

Short Communication

A Vortex Method to Disaggregate Platelets for Correct Counting in Pseudothrombocytopenia

Jianfeng Zhu, Lei Luo, Wei Guo, Beili Wang, Baishen Pan

Short Communication

High Titer Antibodies Demonstrating Prozone in Two Repeat Blood Donors

Sheetal Malhotra, Ashish Jain, Suchet Sachdev, Ratti Ram Sharma

COVID-19 Correspondence

Evaluation of Asymptomatic Covid Infection in Children with Pediatric Hemato-Oncologic Disease

Aysenur Bahadir, Esra Özkaya, Erol Erduran, İlknur Tosun, Gökçe Pinar Reis, Gülay Kaya

Correspondence

Efficacy of Flumatinib in CML Patients with F359V/C Mutation

Hua Gao, Libo Li, Jiao Mu, Jing Tan, Rong Chen

Images

Cancer Cell Leukemia (Carcinocythemia): A rare Presentation of most Common Neoplasm in Females

Amardeep Pathak, Devasis Panda, Narender Tejwani, Anurag Mehta

IMAGES

Unusual Plasma Cell Morphology: A Diagnostic Dilemma

Vidisha Mahajan, Suyash Vishwaroop, Shanaz Khodaiji

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.